GoodRx Holdings (GDRX) Net Cash Flow Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | -420.04% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 9,394.16% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | -564.99% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | -76.26% |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 248.05% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | -131.26% |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -50.15% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | -175.74% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 188.43% |
| 10 | GoodRx Holdings | 1.05 Bn | 814.83 Mn | 112.95 Mn | 82.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82.28% |
| Dec 31, 2025 | -147.66% |
| Sep 30, 2025 | 92.30% |
| Jun 30, 2025 | -134.31% |
| Mar 31, 2025 | -6.02% |
| Dec 31, 2024 | 120.04% |
| Sep 30, 2024 | -407.22% |
| Jun 30, 2024 | -1,019.17% |
| Mar 31, 2024 | -3,655.01% |
| Dec 31, 2023 | -532.04% |
| Sep 30, 2023 | 1,976.68% |
| Jun 30, 2023 | 100.79% |
| Mar 31, 2023 | 104.09% |
| Dec 31, 2022 | -2.43% |
| Sep 30, 2022 | -110.13% |
| Jun 30, 2022 | -16.45% |
| Mar 31, 2022 | -539.47% |
| Dec 31, 2021 | 127.35% |
| Sep 30, 2021 | -98.18% |
| Jun 30, 2021 | -420.45% |
| Mar 31, 2021 | -68.80% |
| Dec 31, 2020 | -216.13% |